Anti-cancer AI equipment developer Lunit will get $61m pre-IPO investment spherical | AltAssets Private Equity News


Cancer-fighting AI developer Lunit has picked up a $61m pre-IPO financing spherical from traders together with HealthQuest Capital and Casdin Capital,

Lunit is operating on AI-powered diagnostic equipment for most cancers screening, in addition to biomarkers that may correctly are expecting and information which sufferers reply to precise most cancers remedy.

The corporate is ready for an IPO at the South Korean inventory marketplace early subsequent 12 months.

HealthQuest Capital invested $20m of the most recent investment spherical. Firm managing spouse Garheng Kong stated, “At HealthQuest, we’re highly interested in AI advancement and its application to complex diagnostic procedures to improve accuracy and reduce complexity.

“Lunit stands out as best-in-class for its state-of-the-art solutions (which uses a paired modality approach) across multiple products, and has significant initial commercial traction around the world.”

Other Lunit backers come with Softbank Ventures Asia, Legend Capital, IMM Investment, Kakao Ventures and Mirae Asset Venture Investment.

Lunit prior to now closed a strategic funding of $26m from Guardant Health final July.

Copyright © 2021 AltAssets

,

Make Money 100% Real:-


Doge Coin Mining


Crypto Tab Browser




Click for Original Content Writer







“Disclaimer”

“We sharing content only for awareness purpose. If you are the owner of this content or material and want to remove this then Mail us, We will remove it as soon as Possible.”
"Contact Us:-"

"News Fall Out"

Originally posted 2021-11-29 10:21:25.

Translate »
%d bloggers like this: